NMIN is collaborating with its partner organization NanoCanada to build a Canadian Nanomedicine Cluster that will offer a hub for collaboration and partnerships, provide a database of expertise and capabilities, and showcase Canada’s leadership on the global stage. As part of this collaboration, NMIN Executive Director Dr. Diana Royce has… Read More »NMIN supports NanoCanada’s Canadian Nanomedicine Cluster initiative
The research in Small featured below is from the laboratories of Drs. Dominik Witzigmann (top center) and Pieter Cullis (bottom left) at UBC and Dr. Dirk Trauner (bottom right) at New York University. The lead authors are Nisha Chander (top right) and Dr. Johannes Morstein (top left). NMIN-supported research has… Read More »Lipid nanoparticles in COPD treatment & for light-triggered anticancer drug release: two NMIN-supported papers
NMIN submitted its second Annual Progress Report to the NCE on 15 June 2021. The report compiled the network’s progress as of the end of 2020-21, accomplished despite the challenges associated with the COVID-19 pandemic. Among the achievements reported: NMIN has made 32 research investments, including 24 research projects, 2… Read More »NMIN’s Annual Progress Report compiles 2020-21 achievements
The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipient of its inaugural NMIN Postdoctoral Award in Diagnostics: Dr. Yih Yang (Ian) Chen. The awardee was selected by the members of NMIN’s Research Management Committee, based on the applicant’s qualifications, as well as the quality of the proposed research… Read More »Inaugural NMIN Postdoctoral Award in Diagnostics winner announced
The NanoMedicines Innovation Network (NMIN) is pleased to announce the inaugural recipients of the NMIN Undergraduate Studentships in NanoMedicines Research. The awardees will receive a stipend of $1,500 a month for a maximum of three months between June 2021 and April 2022, to work on a nanomedicines-related research project under… Read More »Inaugural NMIN Undergraduate Studentships awarded
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the 2021-22 Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the 2021-22 NMIN HQP Network Leadership Team
Top L to R: Brenna Rauw, Stephen Dibert, Inès Holzbaur, Wendy Lamson. Bottom L to R: Lihn Le, Helen Loughrey, Paul Santerre, Andrew Sinclair, Gary Skarja. The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural members of its Commercialization Advisory Board (CAB). The Commercialization Advisory Board (CAB) provides… Read More »Meet NMIN’s Commercialization Advisory Board (CAB)
The NanoMedicines Innovation Network (NMIN), a national research network funded by the Government of Canada, has appointed Dr. Christine Allen Scientific Director & CEO, effective 1 July 2021. Dr. Allen is Associate Vice-President and Vice-Provost, Strategic Initiatives, and Professor in the Leslie Dan Faculty of Pharmacy, at the University of… Read More »NMIN names new Scientific Director & CEO Dr. Christine Allen
Since news of the Pfizer-BioNTech COVID-19 vaccine first broke in November 2020, growing recognition has been given to the Canadian nanomedicine-based component underlying the vaccine’s effectiveness: the lipid nanoparticle (LNP) delivery system that originated from basic research by NMIN Scientific Director Dr. Pieter Cullis that started over 40 years ago… Read More »Recognition grows for role of LNPs and Canadian biotech in COVID-19 mRNA-based vaccines
L to R: Drs. Robert Hancock, Edward Sargent, Pieter Cullis, John Marshall and David Wishart. Five NMIN researchers are numbered among the scholars listed in the 14th edition of “Highly Cited Researchers”—those with an h-index over 100—published by the Webometrics Ranking of World Universities. Among the 4730 scholars in the… Read More »Five NMIN researchers among the most “Highly Cited”